Next Article in Journal
Lessons from the CONSCIOUS-1 Study
Next Article in Special Issue
Sharing Cancer Survivorship Care between Oncology and Primary Care Providers: A Qualitative Study of Health Care Professionals’ Experiences
Previous Article in Journal
Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
Previous Article in Special Issue
Patient and Medical Oncologists’ Perspectives on Prescribed Lifestyle Intervention—Experiences of Women with Breast Cancer and Providers
Article

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

1
Psychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
2
Department of Psychology and Consultation Liaison Psychiatry, Alfred Health, Melbourne, VIC 3004, Australia
3
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
4
Australian Cancer Survivorship Centre, Melbourne, VIC 3000, Australia
5
Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3010, Australia
6
Centre for Oncology Education and Research Translation, Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Kensington, NSW 2052, Australia
7
Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia
8
Centre for Medical Psychology & Evidence-based Decision-making, School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia
9
Department of Psychiatry, The University of Melbourne, Melbourne, VIC 3010, Australia
10
Health Services and Implementation Science, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
11
Department of Skin and Melanoma Service, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
12
School of Nursing and Midwifery, Institute for Health Transformation, Deakin University, Geelong, VIC 3217, Australia
13
Centre for Quality and Patient Safety—Eastern Health Partnership, Box Hill, VIC 3128, Australia
14
Melanoma Patients Australia, Melbourne, VIC 3000, Australia
15
Melanoma Research Victoria Consumer Reference Group, Melbourne, VIC 3000, Australia
16
Australian Melanoma Consumer Alliance, Melbourne, VIC 3000, Australia
17
Department of Medical Oncology, Alfred Health, Melbourne, VIC 3004, Australia
18
Department of Medicine, Monash University, Melbourne, VIC 3010, Australia
19
Centre for Mental Health, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(9), 2969; https://doi.org/10.3390/jcm9092969
Received: 26 July 2020 / Revised: 29 August 2020 / Accepted: 8 September 2020 / Published: 14 September 2020
(This article belongs to the Special Issue Cancer Rehabilitation and Survivorship)
Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease. View Full-Text
Keywords: fear of cancer recurrence; stepped care; metastatic melanoma fear of cancer recurrence; stepped care; metastatic melanoma
Show Figures

Figure 1

MDPI and ACS Style

Lynch, F.A.; Katona, L.; Jefford, M.; Smith, A.B.; Shaw, J.; Dhillon, H.M.; Ellen, S.; Phipps-Nelson, J.; Lai-Kwon, J.; Milne, D.; Russell, L.; Dax, V.; Diggens, J.; Kent, H.; Button-Sloan, A.; Elliott, J.; Shackleton, M.; Burridge, H.; Ftanou, M. Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. J. Clin. Med. 2020, 9, 2969. https://doi.org/10.3390/jcm9092969

AMA Style

Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, Ellen S, Phipps-Nelson J, Lai-Kwon J, Milne D, Russell L, Dax V, Diggens J, Kent H, Button-Sloan A, Elliott J, Shackleton M, Burridge H, Ftanou M. Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. Journal of Clinical Medicine. 2020; 9(9):2969. https://doi.org/10.3390/jcm9092969

Chicago/Turabian Style

Lynch, Fiona A., Lynda Katona, Michael Jefford, Allan B. Smith, Joanne Shaw, Haryana M. Dhillon, Steve Ellen, Jo Phipps-Nelson, Julia Lai-Kwon, Donna Milne, Lahiru Russell, Victoria Dax, Justine Diggens, Holly Kent, Alison Button-Sloan, Jane Elliott, Mark Shackleton, Hayley Burridge, and Maria Ftanou. 2020. "Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma" Journal of Clinical Medicine 9, no. 9: 2969. https://doi.org/10.3390/jcm9092969

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop